LUNG vs WST · rev $43.3M vs P/E 35, rev $1.72B
Pulmonx Corp (LUNG) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported LUNG revenue for 2026-06-30 was $43.3M. Net income was -$23.7M. LUNG currently screens at market cap $111.9M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
LUNG currently screens at market cap $111.9M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the LUNG and WST stock pages for the full models.
Not investment advice.